The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Prevenar



Wyeth Lederle Vaccines S.A.EU/1/00/167/008

Main Information

Trade NamePrevenar
Active SubstancesPneumococcal oligosaccharide serotype 18c
Pneumococcal polysaccharide serotype 9v
Pneumococcal polysaccharide serotype 6b
Pneumococcal polysaccharide serotype 19f
Crm197 carrier protein
Pneumococcal polysaccharide serotype 23f
Pneumococcal polysaccharide serotype 14
Pneumococcal polysaccharide serotype 4
Dosage FormSuspension for injection in pre-filled syringe
Licence HolderWyeth Lederle Vaccines S.A.
Licence NumberEU/1/00/167/008

Group Information

ATC CodeJ07AL Pneumococcal vaccines
J07AL02 pneumococcus, purified polysaccharides antigen conjugated

Status

License statusAuthorised
Licence Issued31/08/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back